Millipede AspiRation for Revascularization in Stroke (MARRS) Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

October 9, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

Millipede System

Mechanical thrombectomy

Trial Locations (23)

11794

Stony Brook University Hospital, Stony Brook

14620

University Of Rochester Medical Center (URMC), Rochester

15213

University of Pittsburgh Medical Center (UPMC), Pittsburgh

28046

Hospital Universitario La Paz, Madrid

30322

Emory, Atlanta

32207

Baptist Health Research Institute, Jacksonville

33076

CHU Bordeaux, Bordeaux

33612

Tampa General Hosital, Tampa

38120

Semmes Murphey Foundation, Memphis

43606

ProMedica Toledo Hospital, Toledo

43608

Mercy Health, Toledo

43614

University of Toledo, Toledo

44093

CHU de Nantes - HGRL, Nantes

60637

University of Chicago, Chicago

67200

CHRU Strasbourg, Strasbourg

77225

UT Houston, Houston

78550

Valley Baptist Medical Center, Harlingen

97239

Oregon Health & Science University (OHSU), Portland

06510

Yale University Hospital, New Haven

Unknown

CHU Montpellier, Montpellier

CHRU de Nancy, Nancy

Toulouse University Hospital -CHU Purpan, Toulouse

Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Perfuze

INDUSTRY

NCT05714501 - Millipede AspiRation for Revascularization in Stroke (MARRS) Study | Biotech Hunter | Biotech Hunter